-
1
-
-
0037029430
-
Treatment of ankylosing spondylitis with infliximab: a randomized controlled multicentre trial
-
10.1016/S0140-6736(02)08215-6, 11955536
-
Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sörensen H, Zeidler H, Thriene W, Sieper J. Treatment of ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002, 359:1187-1193. 10.1016/S0140-6736(02)08215-6, 11955536.
-
(2002)
Lancet
, vol.359
, pp. 1187-1193
-
-
Braun, J.1
Brandt, J.2
Listing, J.3
Zink, A.4
Alten, R.5
Golder, W.6
Gromnica-Ihle, E.7
Kellner, H.8
Krause, A.9
Schneider, M.10
Sörensen, H.11
Zeidler, H.12
Thriene, W.13
Sieper, J.14
-
2
-
-
9644266805
-
Outcomes of a multicentre randomized clinical trial of etanercept to treat ankylosing spondylitis
-
10.1136/ard.2004.020875, 1754832, 15345498
-
Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmartí R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM, Fatenejad S. Outcomes of a multicentre randomized clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 2004, 63:1594-1600. 10.1136/ard.2004.020875, 1754832, 15345498.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1594-1600
-
-
Calin, A.1
Dijkmans, B.A.2
Emery, P.3
Hakala, M.4
Kalden, J.5
Leirisalo-Repo, M.6
Mola, E.M.7
Salvarani, C.8
Sanmartí, R.9
Sany, J.10
Sibilia, J.11
Sieper, J.12
van der Linden, S.13
Veys, E.14
Appel, A.M.15
Fatenejad, S.16
-
3
-
-
33745894976
-
ATLAS Study Group: efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial
-
10.1002/art.21913, 16802350
-
van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC. ATLAS Study Group: efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006, 54:2136-2146. 10.1002/art.21913, 16802350.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2136-2146
-
-
van der Heijde, D.1
Kivitz, A.2
Schiff, M.H.3
Sieper, J.4
Dijkmans, B.A.5
Braun, J.6
Dougados, M.7
Reveille, J.D.8
Wong, R.L.9
Kupper, H.10
Davis, J.C.11
-
4
-
-
26844432745
-
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-bind, randomized, placebo-controlled trial
-
10.1002/art.21306, 16200601, Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group
-
Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, Sharp JT, Ory PA, Perdok RJ, Weinberg MA, . Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-bind, randomized, placebo-controlled trial. Arthritis Rheum 2005, 52:3279-3289. 10.1002/art.21306, 16200601, Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3279-3289
-
-
Mease, P.J.1
Gladman, D.D.2
Ritchlin, C.T.3
Ruderman, E.M.4
Steinfeld, S.D.5
Choy, E.H.6
Sharp, J.T.7
Ory, P.A.8
Perdok, R.J.9
Weinberg, M.A.10
-
5
-
-
19044382942
-
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
-
10.1136/ard.2004.032268, 1755609, 15677701
-
Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005, 64:1150-1157. 10.1136/ard.2004.032268, 1755609, 15677701.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 1150-1157
-
-
Antoni, C.1
Krueger, G.G.2
de Vlam, K.3
Birbara, C.4
Beutler, A.5
Guzzo, C.6
-
6
-
-
0034729950
-
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
-
10.1016/S0140-6736(00)02530-7, 10972371
-
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000, 356:385-390. 10.1016/S0140-6736(00)02530-7, 10972371.
-
(2000)
Lancet
, vol.356
, pp. 385-390
-
-
Mease, P.J.1
Goffe, B.S.2
Metz, J.3
VanderStoep, A.4
Finck, B.5
Burge, D.J.6
-
7
-
-
79551658174
-
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry
-
10.1002/art.30117, 21279995
-
Glintborg B, Østergaard M, Dreyer L, Krogh NS, Tarp U, Hansen MS, Rifbjerg-Madsen S, Lorenzen T, Hetland ML. Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum 2011, 63:382-390. 10.1002/art.30117, 21279995.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 382-390
-
-
Glintborg, B.1
Østergaard, M.2
Dreyer, L.3
Krogh, N.S.4
Tarp, U.5
Hansen, M.S.6
Rifbjerg-Madsen, S.7
Lorenzen, T.8
Hetland, M.L.9
-
8
-
-
78149479826
-
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry
-
10.1136/ard.2009.124446, 20511613
-
Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis 2010, 69:2002-2008. 10.1136/ard.2009.124446, 20511613.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2002-2008
-
-
Glintborg, B.1
Ostergaard, M.2
Krogh, N.S.3
Dreyer, L.4
Kristensen, H.L.5
Hetland, M.L.6
-
9
-
-
54349109184
-
Successful treatment of psoriatic arthritis with rituximab
-
Cohen JD. Successful treatment of psoriatic arthritis with rituximab. Ann Rheum Dis 2008, 67:1647-1348.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1647-11348
-
-
Cohen, J.D.1
-
10
-
-
54449096535
-
The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B
-
Rodríguez-Escalera C, Fernández-Nebro A. The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B. Rheumatology (Oxford) 2008, 47:1732-1733.
-
(2008)
Rheumatology (Oxford)
, vol.47
, pp. 1732-1733
-
-
Rodríguez-Escalera, C.1
Fernández-Nebro, A.2
-
11
-
-
77951608958
-
Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis
-
10.1136/ard.2009.113233, 19700394
-
Cañete JD, Celis R, Hernández V, Pablos JL, Sanmartí R. Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis. Ann Rheum Dis 2010, 69:935-936. 10.1136/ard.2009.113233, 19700394.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 935-936
-
-
Cañete, J.D.1
Celis, R.2
Hernández, V.3
Pablos, J.L.4
Sanmartí, R.5
-
12
-
-
77951025652
-
Abatacept as an option therapy in difficult to treat psoriatic arthritis
-
10.1007/s00296-009-1041-1, 19579026
-
Vieira FJ, Callado MR, Vieira WP. Abatacept as an option therapy in difficult to treat psoriatic arthritis. Rheumatol Int 2010, 30:849-850. 10.1007/s00296-009-1041-1, 19579026.
-
(2010)
Rheumatol Int
, vol.30
, pp. 849-850
-
-
Vieira, F.J.1
Callado, M.R.2
Vieira, W.P.3
-
13
-
-
79953701653
-
Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial
-
10.1002/art.30176, 21128258
-
Mease P, Genovese MC, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, Wollenhaupt J, Bahary O, Becker JC, Kelly S, Sigal L, Teng J, Gladman D. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum 2011, 63:939-948. 10.1002/art.30176, 21128258.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 939-948
-
-
Mease, P.1
Genovese, M.C.2
Genovese, M.C.3
Gladstein, G.4
Kivitz, A.J.5
Ritchlin, C.6
Tak, P.P.7
Wollenhaupt, J.8
Bahary, O.9
Becker, J.C.10
Kelly, S.11
Sigal, L.12
Teng, J.13
Gladman, D.14
-
14
-
-
46449083444
-
Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis
-
10.1016/j.jbspin.2008.01.023, 18457981
-
Wendling D, Augé B, Streit G, Toussirot E, Mathieu S. Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis. Joint Bone Spine 2008, 75:510-511. 10.1016/j.jbspin.2008.01.023, 18457981.
-
(2008)
Joint Bone Spine
, vol.75
, pp. 510-511
-
-
Wendling, D.1
Augé, B.2
Streit, G.3
Toussirot, E.4
Mathieu, S.5
-
15
-
-
77951757221
-
Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial
-
10.1002/art.27383, 20461780
-
Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J, Sieper J. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum 2010, 62:1290-1297. 10.1002/art.27383, 20461780.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 1290-1297
-
-
Song, I.H.1
Heldmann, F.2
Rudwaleit, M.3
Listing, J.4
Appel, H.5
Braun, J.6
Sieper, J.7
-
16
-
-
75749112924
-
Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry
-
10.1136/ard.2008.107102, 20107035
-
Nocturne G, Dougados M, Constantin A, Richez C, Sellam J, Simon A, Wendling D, Mariette X, Gottenberg JE. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis 2010, 69:471-472. 10.1136/ard.2008.107102, 20107035.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 471-472
-
-
Nocturne, G.1
Dougados, M.2
Constantin, A.3
Richez, C.4
Sellam, J.5
Simon, A.6
Wendling, D.7
Mariette, X.8
Gottenberg, J.E.9
-
17
-
-
79955868460
-
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
-
10.1136/ard.2010.145946, 21415053
-
Song IH, Heldmann F, Rudwaleit M, Haibel H, Weiß A, Braun J, Sieper J. Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study. Ann Rheum Dis 2011, 70:1108-1110. 10.1136/ard.2010.145946, 21415053.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1108-1110
-
-
Song, I.H.1
Heldmann, F.2
Rudwaleit, M.3
Haibel, H.4
Weiß, A.5
Braun, J.6
Sieper, J.7
-
18
-
-
84855661105
-
Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis factor inhibition
-
10.1016/j.jbspin.2011.02.018, 21497538
-
Lekpa FK, Farrenq V, Canouï-Poitrine F, Paul M, Chevalier X, Bruckert R, Bastuji-Garin S, Claudepierre P. Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis factor inhibition. Joint Bone Spine 2012, 79:47-50. 10.1016/j.jbspin.2011.02.018, 21497538.
-
(2012)
Joint Bone Spine
, vol.79
, pp. 47-50
-
-
Lekpa, F.K.1
Farrenq, V.2
Canouï-Poitrine, F.3
Paul, M.4
Chevalier, X.5
Bruckert, R.6
Bastuji-Garin, S.7
Claudepierre, P.8
-
19
-
-
0027943397
-
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity
-
10.1093/rheumatology/33.10.927, 7921752
-
Gratacós J, Collado A, Filella X, Sanmartí R, Cañete J, Llena J, Molina R, Ballesta A, Muñoz-Gómez J. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994, 33:927-931. 10.1093/rheumatology/33.10.927, 7921752.
-
(1994)
Br J Rheumatol
, vol.33
, pp. 927-931
-
-
Gratacós, J.1
Collado, A.2
Filella, X.3
Sanmartí, R.4
Cañete, J.5
Llena, J.6
Molina, R.7
Ballesta, A.8
Muñoz-Gómez, J.9
-
20
-
-
0028341585
-
Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis
-
1005360, 8037502
-
Tutuncu ZN, Bilgie A, Kennedy LG, Calin A. Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 1994, 53:425-426. 1005360, 8037502.
-
(1994)
Ann Rheum Dis
, vol.53
, pp. 425-426
-
-
Tutuncu, Z.N.1
Bilgie, A.2
Kennedy, L.G.3
Calin, A.4
-
21
-
-
0030757087
-
A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies
-
10.1093/rheumatology/36.3.400, 9156766
-
Claudepierre P, Rymer JC, Authier FJ, Allanore Y, Larget-Piet B, Gherardi R, Chevalier X. A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies. Br J Rheumatol 1997, 36:400-401. 10.1093/rheumatology/36.3.400, 9156766.
-
(1997)
Br J Rheumatol
, vol.36
, pp. 400-401
-
-
Claudepierre, P.1
Rymer, J.C.2
Authier, F.J.3
Allanore, Y.4
Larget-Piet, B.5
Gherardi, R.6
Chevalier, X.7
-
22
-
-
63049139677
-
Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?
-
Alenius GM, Eriksson C, Rantapää Dahlqvist S. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?. Clin Exp Rheumatol 2009, 27:120-123.
-
(2009)
Clin Exp Rheumatol
, vol.27
, pp. 120-123
-
-
Alenius, G.M.1
Eriksson, C.2
Rantapää Dahlqvist, S.3
-
23
-
-
33744486334
-
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases
-
10.1136/ard.2005.037465, 1798185, 16249231
-
François RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 2006, 65:713-720. 10.1136/ard.2005.037465, 1798185, 16249231.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 713-720
-
-
François, R.J.1
Neure, L.2
Sieper, J.3
Braun, J.4
-
24
-
-
70349402169
-
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
-
10.1136/ard.2008.092866, 2732899, 19019888
-
Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis 2009, 68:1580-1584. 10.1136/ard.2008.092866, 2732899, 19019888.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1580-1584
-
-
Nishimoto, N.1
Miyasaka, N.2
Yamamoto, K.3
Kawai, S.4
Takeuchi, T.5
Azuma, J.6
-
25
-
-
0030476890
-
Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy
-
10.1093/rheumatology/35.12.1330, 9010072
-
Wendling D, Racadot E, Toussirot E, Wijdenes J. Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy. Br J Rheumatol 1996, 35:1330. 10.1093/rheumatology/35.12.1330, 9010072.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 1330
-
-
Wendling, D.1
Racadot, E.2
Toussirot, E.3
Wijdenes, J.4
-
26
-
-
78649907237
-
Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists
-
10.1016/j.jbspin.2010.08.004, 20851032
-
Brulhart L, Nissen MJ, Chevallier P, Gabay C. Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists. Joint Bone Spine 2010, 77:625-626. 10.1016/j.jbspin.2010.08.004, 20851032.
-
(2010)
Joint Bone Spine
, vol.77
, pp. 625-626
-
-
Brulhart, L.1
Nissen, M.J.2
Chevallier, P.3
Gabay, C.4
-
27
-
-
73449141147
-
Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab
-
10.1002/art.24899, 19950316
-
Tanaka T, Kuwahara Y, Shima Y, Hirano T, Kawai M, Ogawa M, Arimitsu J, Hagihara K, Narazaki M, Ogata A, Kawase I, Kishimoto T. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Arthritis Rheum 2009, 61:1762-1764. 10.1002/art.24899, 19950316.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 1762-1764
-
-
Tanaka, T.1
Kuwahara, Y.2
Shima, Y.3
Hirano, T.4
Kawai, M.5
Ogawa, M.6
Arimitsu, J.7
Hagihara, K.8
Narazaki, M.9
Ogata, A.10
Kawase, I.11
Kishimoto, T.12
-
28
-
-
78049418460
-
Mixed response to tocilizumab for ankylosing spondylitis
-
10.1136/ard.2009.126706, 20525837
-
Henes JC, Horger M, Guenaydin I, Kanz L, Koetter I. Mixed response to tocilizumab for ankylosing spondylitis. Ann Rheum Dis 2010, 69:2217-2218. 10.1136/ard.2009.126706, 20525837.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2217-2218
-
-
Henes, J.C.1
Horger, M.2
Guenaydin, I.3
Kanz, L.4
Koetter, I.5
-
29
-
-
78649904087
-
Short-term effect of IL-6 inhibition in spondylarthritis
-
10.1016/j.jbspin.2010.09.011, 20971669
-
Wendling D, Bossert M, Prati C. Short-term effect of IL-6 inhibition in spondylarthritis. Joint Bone Spine 2010, 77:624-625. 10.1016/j.jbspin.2010.09.011, 20971669.
-
(2010)
Joint Bone Spine
, vol.77
, pp. 624-625
-
-
Wendling, D.1
Bossert, M.2
Prati, C.3
-
30
-
-
20344381320
-
The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
-
10.1517/14712598.5.5.683, 15934843
-
Mihara M, Nishimoto N, Ohsugi Y. The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. Expert Opin Biol Ther 2005, 5:683-690. 10.1517/14712598.5.5.683, 15934843.
-
(2005)
Expert Opin Biol Ther
, vol.5
, pp. 683-690
-
-
Mihara, M.1
Nishimoto, N.2
Ohsugi, Y.3
-
31
-
-
84859100471
-
Club Rhumatismes et Inflammation
-
Club Rhumatismes et Inflammation. , http://www.cri-net.com
-
-
-
-
32
-
-
67449128733
-
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
-
10.1136/ard.2009.108233, 19297344
-
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777-783. 10.1136/ard.2009.108233, 19297344.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 777-783
-
-
Rudwaleit, M.1
van der Heijde, D.2
Landewé, R.3
Listing, J.4
Akkoc, N.5
Brandt, J.6
Braun, J.7
Chou, C.T.8
Collantes-Estevez, E.9
Dougados, M.10
Huang, F.11
Gu, J.12
Khan, M.A.13
Kirazli, Y.14
Maksymowych, W.P.15
Mielants, H.16
Sørensen, I.J.17
Ozgocmen, S.18
Roussou, E.19
Valle-Oñate, R.20
Weber, U.21
Wei, J.22
Sieper, J.23
more..
-
33
-
-
78650679234
-
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
-
10.1136/ard.2010.133645, 21109520
-
Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70:25-31. 10.1136/ard.2010.133645, 21109520.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 25-31
-
-
Rudwaleit, M.1
van der Heijde, D.2
Landewé, R.3
Akkoc, N.4
Brandt, J.5
Chou, C.T.6
Dougados, M.7
Huang, F.8
Gu, J.9
Kirazli, Y.10
Van den Bosch, F.11
Olivieri, I.12
Roussou, E.13
Scarpato, S.14
Sørensen, I.J.15
Valle-Oñate, R.16
Weber, U.17
Wei, J.18
Sieper, J.19
-
34
-
-
0021272107
-
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
-
10.1002/art.1780270401, 6231933
-
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368. 10.1002/art.1780270401, 6231933.
-
(1984)
Arthritis Rheum
, vol.27
, pp. 361-368
-
-
van der Linden, S.1
Valkenburg, H.A.2
Cats, A.3
-
36
-
-
0026003027
-
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
-
10.1002/art.1780341003, 1930310
-
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227. 10.1002/art.1780341003, 1930310.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1218-1227
-
-
Dougados, M.1
van der Linden, S.2
Juhlin, R.3
Huitfeldt, B.4
Amor, B.5
Calin, A.6
Cats, A.7
Dijkmans, B.8
Olivieri, I.9
Pasero, G.10
Veys, E.11
Zeidler, H.12
-
37
-
-
33746951437
-
Classification criteria for psoriatic arthritis: development of new criteria from a large international study
-
10.1002/art.21972, 16871531, CASPAR Study Group
-
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, . CASPAR Study Group Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673. 10.1002/art.21972, 16871531, CASPAR Study Group.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2665-2673
-
-
Taylor, W.1
Gladman, D.2
Helliwell, P.3
Marchesoni, A.4
Mease, P.5
Mielants, H.6
-
38
-
-
33144469246
-
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
-
10.1136/ard.2005.040758, 1798064, 16096329, ASAS Working Group
-
Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, . ASAS Working Group First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006, 65:316-320. 10.1136/ard.2005.040758, 1798064, 16096329, ASAS Working Group.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 316-320
-
-
Braun, J.1
Davis, J.2
Dougados, M.3
Sieper, J.4
van der Linden, S.5
van der Heijde, D.6
-
39
-
-
84855674874
-
Tocilizumab in axial spondylarthritis: about 18 cases
-
10.1136/ard.2010.132662, 21062853
-
Dudler J, Aubry-Rozier B. Tocilizumab in axial spondylarthritis: about 18 cases. Ann Rheum Dis 2011, 70:128. 10.1136/ard.2010.132662, 21062853.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 128
-
-
Dudler, J.1
Aubry-Rozier, B.2
-
40
-
-
84855672444
-
Tocilizumab for treatment of refractory spondylarthritis: report of 5 patients
-
Del Castillo Piñol N, Gossec L, Sparsa L, Roux C, Dougados M. Tocilizumab for treatment of refractory spondylarthritis: report of 5 patients. Ann Rheum Dis 2011, 70:343.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 343
-
-
Del Castillo Piñol, N.1
Gossec, L.2
Sparsa, L.3
Roux, C.4
Dougados, M.5
-
41
-
-
77955001179
-
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis
-
10.1136/ard.2010.129148, 20498200
-
Hayer S, Niederreiter B, Nagelreiter I, Smolen J, Redlich K. Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis. Ann Rheum Dis 2010, 69:1403-1406. 10.1136/ard.2010.129148, 20498200.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1403-1406
-
-
Hayer, S.1
Niederreiter, B.2
Nagelreiter, I.3
Smolen, J.4
Redlich, K.5
-
42
-
-
38649126902
-
Sustained response to anakinra in ankylosing spondylitis
-
Bennett AN, Tan AL, Coates LC, Emery P, Marzo-Ortega H, McGonagle D. Sustained response to anakinra in ankylosing spondylitis. Rheumatology (Oxford) 2008, 47:223-224.
-
(2008)
Rheumatology (Oxford)
, vol.47
, pp. 223-224
-
-
Bennett, A.N.1
Tan, A.L.2
Coates, L.C.3
Emery, P.4
Marzo-Ortega, H.5
McGonagle, D.6
-
43
-
-
13244279795
-
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks
-
10.1136/ard.2004.023176, 1755331, 15208175
-
Haibel H, Rudwaleit M, Listing J, Sieper J. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann Rheum Dis 2005, 64:296-298. 10.1136/ard.2004.023176, 1755331, 15208175.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 296-298
-
-
Haibel, H.1
Rudwaleit, M.2
Listing, J.3
Sieper, J.4
-
44
-
-
79952113703
-
An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)
-
10.1007/s10067-010-1504-5, 20532937
-
Jung N, Hellmann M, Hoheisel R, Lehmann C, Haase I, Perniok A, Hallek M, Rubbert A. An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin Rheumatol 2010, 29:1169-1173. 10.1007/s10067-010-1504-5, 20532937.
-
(2010)
Clin Rheumatol
, vol.29
, pp. 1169-1173
-
-
Jung, N.1
Hellmann, M.2
Hoheisel, R.3
Lehmann, C.4
Haase, I.5
Perniok, A.6
Hallek, M.7
Rubbert, A.8
-
45
-
-
84855974706
-
Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonists
-
10.1016/j.jbspin.2011.05.023, 21803631
-
Wendling D, Prati C. Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonists. Joint Bone Spine 2011, 78:542-544. 10.1016/j.jbspin.2011.05.023, 21803631.
-
(2011)
Joint Bone Spine
, vol.78
, pp. 542-544
-
-
Wendling, D.1
Prati, C.2
|